ELICIO THERAPEUTICS ($ELTX) posted quarterly earnings results for Q1 2026 on Monday, May 11th. The company reported earnings of -$0.65 per share, missing estimates of -$0.47 by $0.18. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ELTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ELICIO THERAPEUTICS Hedge Fund Activity
We have seen 23 institutional investors add shares of ELICIO THERAPEUTICS stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- 683 CAPITAL MANAGEMENT, LLC added 56,442 shares (+inf%) to their portfolio in Q4 2025, for an estimated $449,278
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 56,155 shares (-46.7%) from their portfolio in Q4 2025, for an estimated $446,993
- MARSHALL WACE, LLP added 30,667 shares (+35.4%) to their portfolio in Q4 2025, for an estimated $244,109
- IRIDIAN ASSET MANAGEMENT LLC/CT added 30,051 shares (+inf%) to their portfolio in Q1 2026, for an estimated $321,245
- CRESSET ASSET MANAGEMENT, LLC removed 26,925 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $214,323
- OMERS ADMINISTRATION CORP added 23,500 shares (+inf%) to their portfolio in Q4 2025, for an estimated $187,060
- VANGUARD GROUP INC added 23,042 shares (+4.9%) to their portfolio in Q4 2025, for an estimated $183,414
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ELICIO THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $ELTX recently. We have seen 3 analysts offer price targets for $ELTX in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- Aydin Huseynov from Ladenburg Thalmann set a target price of $20.0 on 04/15/2026
- Robert Burns from HC Wainwright & Co. set a target price of $17.0 on 03/13/2026
- Michael King from Rodman & Renshaw set a target price of $17.0 on 03/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
